PGI2-generation and antithrombotic activity of orally administered defibrotide.
D000818:Animals; D001011:Aorta / Q000378:metabolism; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D003094:Collagen; D006224:Cricetinae; D004247:DNA / Q000494:pharmacology; D011464:Epoprostenol / Q000096:biosynthesis*; D005343:Fibrinolytic Agents; D008297:Male; D008647:Mesocricetus; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D011089:Polydeoxyribonucleotides / Q000494:pharmacology*; D011453:Prostaglandins / Q000096:biosynthesis*; D011817:Rabbits; D013442:Sulfinpyrazone / Q000494:pharmacology; D013924:Thrombophlebitis / Q000139:chemically induced / Q000188:drug therapy
D001095:Arachidonic Acids; D005343:Fibrinolytic Agents; D011089:Polydeoxyribonucleotides; D011453:Prostaglandins; D016718:Arachidonic Acid; C036901:defibrotide; D003094:Collagen; D004247:DNA; D011464:Epoprostenol; D013442:Sulfinpyrazone